Delivering an FDA-cleared healthcare solution in the shortest time possible required more than a skilled engineering team. Accelerated Diagnostics, Inc. needed a software version control solution that was intuitive and provided full visibility throughout development to deliver a high quality product.
The Centers for Disease Control and Prevention estimate at least two million people each year are infected with antibiotic resistant bacteria across the USA. In addition, antibiotic resistance contributes to the mortality of healthcare-associated infections that kill an estimated 75,000 people annually. Early diagnosis of antibiotic resistant bacteria is critical to providing effective treatment. The only way to know which therapy will work is to test a range of antibiotics. Typical conventional antibiotic susceptibility testing requires time-consuming manual procedures, often exceeding 48 hours, leaving clinicians with incomplete information to provide definitive treatment during this critical time period.
The technology from Accelerate Diagnostics allows laboratories to substantially reduce the time to results by testing directly from positive blood culture samples, enabling clinicians to provide optimal antibiotic therapy up to 40 hours faster than conventional methods.
Paul Richards, Software Engineer for Accelerate Diagnostics, explains the role software plays in this process: “When we started Accelerate Diagnostics in 2012, we knew we had a potentially life-saving concept. The key was to bring it to market as soon as possible. Despite having a small engineering team, we accomplished in four years what many in the diagnostics industry take nearly a decade to do: move from technological concepts to an FDA-cleared and ready-to-use solution that offers value to our healthcare customers. Our software development process was critical to this progress and required a set of tools which were reliable and easy to work with.”